invokana

Generic: canagliflozin

Labeler: cardinal health 107, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name invokana
Generic Name canagliflozin
Labeler cardinal health 107, llc
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

canagliflozin 100 mg/1

Manufacturer
Cardinal Health 107, LLC

Identifiers & Regulatory

Product NDC 55154-1425
Product ID 55154-1425_aad6a5e4-0449-44dd-8bb7-e9b17a1fbbc3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA204042
Listing Expiration 2027-12-31
Marketing Start 2013-03-29

Pharmacologic Class

Classes
p-glycoprotein inhibitors [moa] sodium-glucose cotransporter 2 inhibitor [epc] sodium-glucose transporter 2 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 551541425
Hyphenated Format 55154-1425

Supplemental Identifiers

RxCUI
1373463 1373469 1373471 1373473
UPC
0355154142589 0350458141306
UNII
0SAC974Z85

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name invokana (source: ndc)
Generic Name canagliflozin (source: ndc)
Application Number NDA204042 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 2070 TABLET, FILM COATED in 1 BOTTLE (55154-1425-8)
source: ndc

Packages (1)

55154-1425-8 2070 TABLET, FILM COATED in 1 BOTTLE (55154-1425-8)

Ingredients (1)

canagliflozin (100 mg/1)

Linked Drug Pages (1)

INVOKANA ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "aad6a5e4-0449-44dd-8bb7-e9b17a1fbbc3", "openfda": {"upc": ["0355154142589", "0350458141306"], "unii": ["0SAC974Z85"], "rxcui": ["1373463", "1373469", "1373471", "1373473"], "spl_set_id": ["5f76e16f-0c24-454a-81af-4080b312c940"], "manufacturer_name": ["Cardinal Health 107, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "2070 TABLET, FILM COATED in 1 BOTTLE (55154-1425-8)", "package_ndc": "55154-1425-8", "marketing_start_date": "20130329"}], "brand_name": "INVOKANA", "product_id": "55154-1425_aad6a5e4-0449-44dd-8bb7-e9b17a1fbbc3", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["P-Glycoprotein Inhibitors [MoA]", "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "55154-1425", "generic_name": "canagliflozin", "labeler_name": "Cardinal Health 107, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "INVOKANA", "active_ingredients": [{"name": "CANAGLIFLOZIN", "strength": "100 mg/1"}], "application_number": "NDA204042", "marketing_category": "NDA", "marketing_start_date": "20130329", "listing_expiration_date": "20271231"}